熟妇乱在线观看,男人插女人下面在线播放,精品亚洲成a人片在线观看,午夜性生活免费看的视频

服務(wù)熱線

15021010459
技術(shù)文章
當(dāng)前位置:主頁 > 技術(shù)文章 > Ariad抗癌藥Iclusig重返市場

Ariad抗癌藥Iclusig重返市場

更新時(shí)間:2014-01-20 點(diǎn)擊次數(shù):1653

    去年Ariad Pharmaceuticals公司業(yè)績由于主打抗癌藥物Iclusig被緊急下架而遭受重創(chuàng)。公司一度陷入困境并將其在美國的員工裁員160人,約占美 國分部總員工數(shù)的40%,以節(jié)省開支。不過現(xiàn)在Ariad Pharmaceuticals公司迎來一絲曙光。公司已經(jīng)著手將Iclusig重新推向市場。此次Ariad將把Iclusig的適用癥范圍縮小,并在 藥物包裝上標(biāo)明可能出現(xiàn)的副作用如心臟病、血液凝塊等。不過由于Iclusig適用范圍變小,公司的收入可能也會大受影響。為解決這一問題公司計(jì)劃申請重 啟此前被FDA下令暫停的關(guān)于Iclusig治療慢性白血病的研究計(jì)劃以達(dá)到亡羊補(bǔ)牢的作用。

    不過Ariad Pharmaceuticals公司的這一系列舉措能否獲得預(yù)期效果還需要等待公司2014年*季度財(cái)報(bào)公布后才能知曉。

詳細(xì)英文報(bào)道:

    Last year, Ariad Pharmaceuticals ($ARIA) watched more than $2.5 billion melt off its market cap when the cancer-fighting Iclusig began a downward spiral that would eventually remove it from the market. But now begins the rebuilding project, as the Cambridge, MA, drugmaker has relaunched its sole product with a lot of ground to make up.

    The drug is now indicated for a smaller group of leukemia patients than before, and it carries a serious boxed warning about the risk of clotting and heart failure that got it pulled from shelves in the fall. But it is for sale, and that puts Ariad in a better place than many predicted at its nadir.

    "We are back on track," CEO Harvey Berger told Bloomberg last month. "We'll enter 2014 largely where we were as we started off the fall in September."

    Of course, that's not entirely the case. Losing more than half of its value forced Ariad to considerably thin its ranks, laying off 40% of its U.S. workforce--or 160 employees--in an effort to save $26 million. Now the company plans to gradually ramp up stateside sales with the help of specialty pharmacy Biologics, Inc., first looking to transition the case-by-case patients who were still using the drug during its marketing hiatus.

    And the company has a long way to go on the R&D side. When the storm over Iclusig began, Ariad was in the process of testing the drug in a broader population, but an FDA-imposed clinical hold led the company to discontinue a Phase III study on patients with newly diagnosed chronic myeloid leukemia and put the brakes on a fleet of Phase II studies designed to expand the drug's market. Berger has said that Ariad is yet to decide just how to move forward with its paused programs.

    Still, the biotech is undeniably sitting prettier than it was just two months ago, and its next big test will come when Q1 sales figures roll in.——(華雅干細(xì)胞整理報(bào)道)

2025 版權(quán)所有 © 重慶市華雅干細(xì)胞技術(shù)有限公司  備案號:渝ICP備14000349號-4 sitemap.xml 管理登陸 技術(shù)支持:化工儀器網(wǎng)

地址:重慶市江北區(qū)金渝大道153號8棟20-14 傳真:023-63419626 郵件:sales@ys-bio.com

重慶市華雅干細(xì)胞技術(shù)有限公司主要經(jīng)營干細(xì)胞研究 干細(xì)胞治療產(chǎn)品 生物試劑 實(shí)驗(yàn)耗材 藥物研發(fā)等產(chǎn)品。

關(guān)注我們

服務(wù)熱線

400-021-2200

掃一掃,關(guān)注我們

国产精品一区久久人人爽| 中文字幕日韩精品 一区| 欧美—区二区视频在线观看| 免费无码aⅤ视频免费看| 国产亚洲视频在线观看播放| 国产精品国产三级国产有无| 小13箩利洗澡无码视频网站免费| 国产亚洲91日韩精品激情| 国产老熟女高潮精品久久久| 久久久久久久夜夜夜夜夜| 国产精品久久久久福利电影| 国产色按摩视频在线播放| 久久精品国产自在天天现| 精品国产偷窥一区二区| 在线视频免费观看短视频| 她也色在线视频色999| 久久亚洲国产成人精品小说| 国产大黑屌精品在线观看 | 亚洲 欧美 另类 综合| 色老头在线一区二区三区| 成人区人妻精品黑人AV| 国产蜜臀一区二区三区四区| 青草视频在线播放| 色偷偷久久一区二区三区| 亚洲网友自拍偷拍有码区| 国产午夜小电影| 久久久久亚洲AV无码去区首| 国产精品毛片av不卡在线| 人妻午夜精品久久久久久久| 日韩高清 中文字幕 一区| 国产午夜精品播放一二三区| 黄色亚洲青娱乐| 午夜国产精品午夜福利网| 亚洲午夜av久久久精品影院色戒 | 日韩美人妻有码无码专区| 国产大尺度视频在线观看| 国产成人精品一区二区无| 国产人妻人伦精品免费看| 少妇文学激情网在线观看| 在线视频一区二区在线视频| 曰韩精品无码一区二区三区|